Mark E. Saad
Insider
IndividualSelling only6 10b5-1 trades
- 2025
- Jun 11, 2026
- 5
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark E. Saad files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- Nick Pizzie - $10.18M in AXSM purchases and sales in the last 12 months
- Mark L. Jacobson - $8.90M in AXSM purchases and sales in the last 12 months
- Mark Coleman - $8.21M in AXSM purchases and sales in the last 12 months
- Ari Maizel - $2.75M in AXSM purchases and sales in the last 12 months
- Susan Mahony - $145K in AXSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark E. Saad?
Mark E. Saad is a corporate insider of Axsome Therapeutics, Inc. (AXSM). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mark E. Saad last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 5 filings going back to 2025.
Has Mark E. Saad been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($7.35M) across all tracked filings.
